Latest Strategic Pivot News

Australian Dairy Nutritionals reported a 47% reduction in net loss for FY26, driven by a 66% revenue jump in its nutritional powders segment, which now makes up 70% of total revenue.

Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.

BlackWall Limited posted a $2.4 million statutory loss for FY2026, driven by operating setbacks and unrealised asset write-downs. The company suspends dividends after exhausting franking credits and proposes a share buy-back offering WOT securities in lieu of cash.

Integrated Research’s FY26 results reveal a sharp 91% drop in net profit amid softer renewals and rising expenses, offset by a 27% jump in cash and a special dividend. The company pushes forward with AI-powered products despite early-stage commercialisation risks.

Strata Investment Holdings delivered a £16.48 million comprehensive profit for H1 2026, driven by a strong revaluation of its investment portfolio and maiden royalty income from Botswana copper assets.

TALi Digital Limited (ASX: TD1) posted a 416% jump in revenue for FY26 but also recorded a $2.2 million loss driven by a $1.3 million impairment of its YCDI! intangible assets. The company is pursuing growth through AI-focused acquisitions and a $3.3 million capital raise.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Calix Limited posted a 16% revenue increase to $39.2 million in FY26 driven by strong growth in its Magnesia business, while reporting a substantial net loss of $51 million largely due to a one-off impairment. The company advanced key industrial decarbonisation projects and strengthened strategic partnerships, focusing on capital-light commercialisation.

Hiremii Limited posted an 8.6% revenue increase to $32.4 million and halved its net loss in FY26, reaching adjusted EBITDA breakeven as it prepares to rebrand as AQYR Limited.

Atturra Limited’s FY26 results reveal a sharp net loss driven by a $22.8 million goodwill impairment, overshadowing a 17% revenue increase to $351.8 million. The company is banking on AI and strategic acquisitions to fuel a turnaround in FY27.

Veris Limited lifted revenue by 4.9% to $102 million in FY26, driven by digital and advisory growth, but statutory net profit fell 67% amid one-off costs and macroeconomic headwinds.

Scales Corporation delivered a record first half in 2026 with revenues soaring 105% to NZ$762.1 million and underlying EBITDA up 18% to NZ$102.2 million. The diversified agribusiness raised its full year profit guidance despite challenges in Europe and the Middle East.